People taking metformin or phentermine alongside tirzepatide should have their provider coordinate their treatment plan
Rovira Guasch R, Ravents Estell A, Mart-Henneberg R, Closa Monasterolo R
Because booming consumer demand for GLP-1s was a primary reason for the shortages, it was a gold rush situation for compounders who made full use of regulatory gaps to build a large secondary market for their compounded GLP-1s by advertising the benefits without disclosing the risks
It reflects the reality that individual biology creates enormous variation in drug response
Instead of relying on subjective feelings, measure objective health markers
Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al